Epiendo pharmaceuticals events
WebPhone Number 00 354 454 0090 EpiEndo is a clinical-stage biopharmaceutical company with a unique approach to inflammatory disorders that focuses on the enhancement of epithelial barrier integrity as a causal pathophysiological factor underlying the etiology of a number of major diseases. WebApr 13, 2024 · EpiEndo is a clinical-stage biopharmaceutical company with a unique approach to inflammatory disorders that focuses on the enhancement of epithelial barrier …
Epiendo pharmaceuticals events
Did you know?
WebPhone Number 00 354 454 0090. EpiEndo is a clinical-stage biopharmaceutical company with a unique approach to inflammatory disorders that focuses on the enhancement of … WebDec 19, 2024 · EpiEndo Pharmaceuticals Overview Update this profile Founded 2014 Status Private Employees 17 Latest Deal Type Series A Latest Deal Amount $23.6M Investors 7 General Information Description Developer of drugs and proprietary compounds intended to offer new treatments for chronic airway diseases.
WebApr 15, 2024 · REYKJAVIK, ICELAND – 15 April 2024 – EpiEndo Pharmaceuticals (www.epiendo.com), a clinical-stage biopharmaceutical company developing novel non-antibiotic macrolide therapeutics for the … WebApr 6, 2024 · EpiEndo is a clinical-stage biopharmaceutical company with a unique approach to inflammatory disorders that focuses on the enhancement of epithelial barrier integrity as a causal pathophysiological factor underlying the etiology of …
WebEpiEndo Pharmaceuticals Raises €800,000 to Advance Breakthrough Treatments for Respiratory Diseases EpiEndo is pleased to announce that we have successfully closed … WebFeb 24, 2024 · EpiEndo’s lead drug candidate, EP395, aims to be the first on-market oral, disease modifying, non-antibiotic, barrier strengthening and anti-inflammatory macrolide for COPD. For more information ...
WebOct 25, 2024 · REYKJAVIK, ICELAND – 25 October 2024 – EpiEndo Pharmaceuticals (www.epiendo.com) is pleased to announce that it is the recipient of this year’s Rising Star Award at the Swedish American Life Science Summit (SALSS). EpiEndo is a privately held biopharmaceutical company focused on a novel barrier enhancing approach to the …
WebAug 18, 2024 · EpiEndo is a clinical-stage biopharmaceutical company with a unique approach to inflammatory disorders that focuses on enhancement of epithelial barrier integrity as a critical pathophysiological factor underlying the etiology of … coordinated family care middlesexWebNov 15, 2024 · Labiotech.eu covers the global biotech industry, read by 150,000+ monthly visitors. Hope you'll enjoy our Biotech News! coordinated family care addressWebFeb 24, 2024 · EpiEndo Pharmaceuticals is a privately held biopharmaceutical company currently developing a next-generation therapeutic platform for the treatment of inflammatory disorders through … famous black union soldiersWebAug 18, 2024 · EpiEndo’s development rationale is based on a newly acknowledged therapeutic paradigm, that loss of integrity of epithelial barriers plays a critical role in … coordinated family care sharepointWebOct 25, 2024 · EpiEndo is a clinical-stage biopharmaceutical company with a unique approach to inflammatory disorders that focuses on enhancement of epithelial barrier integrity as a critical pathophysiological... coordinated entry thurston county waWebOct 23, 2024 · EpiEndo is developing a candidate drug with a novel mode of action that, if successfully brought to the patients, could change the treatment paradigm for COPD,” said Eugen Steiner, member of the award jury. “EpiEndo won the top scores from all judges in the criteria of innovation and impact, giving it the lead over competitors. coordinated family care portalcoordinated family care north brunswick